bioRxivCancer BiologyPreprint
Tunneling nanotubes contribute to the stroma-mediated imatinib resistance of leukemic cells
Marta D. Kolba, Wioleta Dudka, Monika Zaręba-Kozioł, Agata KominekiD, Paolo RonchiiD, Laura Turos, Jakub Wlodarczyk, Yannick SchwabiD, Dominik Cysewski, Katja Srpan, Daniel M. Davis, Katarzyna PiwockaiD
Abstract
Intercellular communication within the bone marrow niche significantly influences leukemogenesis and the sensitivity of leukemic cells to therapy. Tunneling nanotubes (TNTs) are a novel mode of intercellular cross-talk. They are long, thin membranous protrusions that enable the direct transfer of various cargo between cells. Here we show that TNTs are formed between leukemic and bone marrow stromal cells. Fluorescence confocal microscopy with 3D reconstructions, correlative light-electron microscopy and electron tomography provided evidence that TNTs transfer cellular vesicles between cells. The quantitative analysis demonstrated that the stromal cells stimulate TNT-mediated vesicle transfer towards leukemic cells. Transfer of vesicular cargo from stromal cells correlated with increased resistance to anti-leukemic treatment. Moreover, specific sets of proteins with a potential role in survival and the drug response were transferred within these vesicles. Altogether, we found that TNTs are involved in the leukemia-stroma cross-talk and the stroma-mediated cytoprotection of leukemic cells. Our findings implicate TNT connections as a possible target for therapeutic interventions within the leukemia microenvironment to attenuate stroma-conferred protection.
- organism: human
- assay: imaging
- research focus: cell-cell communication
- approach: microscopy & imaging analysis
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- INTERFERON ALPHA AND KINASE INHIBITOR NILOTINIB INCREASE CELL ADHESION AND TUNNELING NANOTUBES IN CML
Maria Omsland, Vibeke Andresen, … Bjørn Tore Gjertsen·bioRxiv·Sep 13, 2018
- The molecular architecture of tunneling nanotubes
Eva Pauline Karasmanis, Siyu Chen, … Samara L. Reck‐Peterson·bioRxiv·May 28, 2026
- Tunnelling nanotubules are druggable mediators of cancer-niche crosstalk.
S. Hockney, J. Parker, … D. Pal·bioRxiv·Jun 20, 2023
- Tunneling nanotubes mediate mitochondrial homeostasis in cancer
Inés Sáenz‐de‐Santa‐María, Anna Pepe, … Chiara Zurzolo·bioRxiv·Jun 15, 2026
- Patient-derived Glioblastoma Stem cells transfer mitochondria through Tunneling Nanotubes in Tumor Organoids
G. PINTO, I. SAENZ DE SANTA MARIA, … C. ZURZOLO·bioRxiv·Nov 21, 2020
- Proteomic landscape of tunneling nanotubes reveals CD9 and CD81 tetraspanins as key regulators
R. Notario Manzano, T. Chaze, … C. Brou·bioRxiv·Dec 21, 2022